CCR2 and atherosclerosis: As expected, given that M249K was by far the most frequent among computationally predicted damaging CCR2 variants, we found associations with a lower risk of the combined atherosclerosis endpoint, as well as significantly lower risk of severe atherosclerosis (manifestations in ≥2 vascular beds, Figure 4B), similar to the burden test.